5-amino-2-aminomethyl-6-[4,6-diamino-3-(4-amino-6-azidomethyl-3,5-dihydroxytetrahydro-2H-2-pyranyloxy)-2-hydroxycyclohexyloxy]tetrahydro-2H-3,4-pyrandiol

ID: ALA285687

Chembl Id: CHEMBL285687

PubChem CID: 14846575

Max Phase: Preclinical

Molecular Formula: C18H36N8O9

Molecular Weight: 508.53

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  [N-]=[N+]=NCC1OC(OC2C(N)CC(N)C(OC3OC(CN)C(O)C(O)C3N)C2O)C(O)C(N)C1O

Standard InChI:  InChI=1S/C18H36N8O9/c19-2-6-11(28)12(29)9(23)17(32-6)34-15-4(20)1-5(21)16(14(15)31)35-18-13(30)8(22)10(27)7(33-18)3-25-26-24/h4-18,27-31H,1-3,19-23H2

Standard InChI Key:  HWKXZVZSOIIGCN-UHFFFAOYSA-N

Associated Targets(non-human)

Lypla1 Lysosomal phospholipase A1 (40 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 508.53Molecular Weight (Monoisotopic): 508.2605AlogP: -6.01#Rotatable Bonds: 7
Polar Surface Area: 316.93Molecular Species: ZWITTERIONHBA: 15HBD: 10
#RO5 Violations: 3HBA (Lipinski): 17HBD (Lipinski): 15#RO5 Violations (Lipinski): 3
CX Acidic pKa: -10.23CX Basic pKa: 9.54CX LogP: -6.35CX LogD: -12.68
Aromatic Rings: Heavy Atoms: 35QED Weighted: 0.09Np Likeness Score: 1.20

References

1. Mingeot-Leclercq MP, Van Schepdael A, Brasseur R, Busson R, Vanderhaeghe HJ, Claes PJ, Tulkens PM..  (1991)  New derivatives of kanamycin B obtained by modifications and substitutions in position 6''. 2. In vitro and computer-aided toxicological evaluation with respect to interactions with phosphatidylinositol.,  34  (4): [PMID:2016725] [10.1021/jm00108a036]

Source